Alemtuzumab, sold under the brand name Campath among others, is a medication used to treat chronic lymphocytic leukemia (CLL) and multiple sclerosis.

This medical drug in use ( in several countries - Russia as example) for immune-suppression of kidney and liver transplants, as preparation against transplant rejection.

What kind mechanisms of immune-suppression in use for this preparation?

Could you explain?

More Dmitri Popov's questions See All
Similar questions and discussions